Related Experiment Videos
Effects of morphine in the isolated mouse urinary bladder
General Pharmacology
|January 1, 1986
Summary
Acute morphine affects mouse urinary bladder responses to acetylcholine. Chronic morphine and other opioids like methadone do not directly impact bladder function, suggesting no opiate receptors are present.
Area of Science:
- Pharmacology
- Neuroscience
- Urology
Background:
- Opioids, such as morphine, are known for their effects on the central nervous system.
- Their influence on peripheral organs, like the urinary bladder, is less understood.
- Investigating opioid interactions with the bladder is crucial for understanding potential side effects and therapeutic applications.
Purpose of the Study:
- To investigate the effects of acute and chronic morphine administration on the isolated mouse urinary bladder.
- To examine the influence of other opioids, methadone and ketocyclazocine, on bladder responses.
- To determine the presence and role of opiate receptors in the mouse urinary bladder neuroeffector junction.
Main Methods:
- Isolated mouse urinary bladder preparations were used.
- Responses to acetylcholine (ACh) and adenosine triphosphate (ATP) were measured.
- Electrical field stimulation was employed to assess neurogenic contractions.
- The effects of acute and chronic morphine, methadone, ketocyclazocine, and naloxone were evaluated.
Main Results:
- Acute morphine administration enhanced bladder responses to acetylcholine.
- Chronic morphine treatment did not alter responses to acetylcholine or ATP.
- Morphine did not affect the contractile response to ATP in either untreated or chronically treated mice.
- Methadone and ketocyclazocine reduced responses to electrical stimulation, an effect not reversed by naloxone.
Conclusions:
- The findings suggest the absence of functional opiate receptors in the mouse urinary bladder.
- Morphine does not appear to have direct effects on the bladder's neuroeffector junction.
- Opioid effects on the urinary bladder may be indirect or mediated through pathways other than classical opiate receptors.